Product Details
Selective Androgen Receptor Modulator (SARM) | Tissue-Selective Anabolism, Lean Mass Accumulation & Bone Mineral Density
Overview:
LGD-4033 (Ligandrol) is an orally active, non-steroidal Selective Androgen Receptor Modulator (SARM) engineered to bind to androgen receptors with high affinity and selectivity. By specifically targeting androgenic receptors in skeletal muscle and bone tissue while sparing prostate and seminal vesicle tissues, LGD-4033 stimulates significant cellular protein synthesis, drives heavy nitrogen retention, and enhances bone mineral density without causing severe androgenic or estrogenic side effects.
This product is supplied as a secure bottle containing 50 oral tablets, with each tablet accurately dosed at 10mg of active LGD-4033.
Why Choose LGD-4033 (10mg) (50 Tablets)?
LGD-4033 is widely recognized as one of the most potent mass-building SARMs available. Unlike traditional anabolic steroids that convert to estrogen or cause fluid bloat, LGD-4033 promotes clean, high-density lean muscle gains and rapid strength increases.
Its tissue-selective nature minimizes unwanted side effects on non-target organs while maintaining a high anabolic impact on muscle tissue. The 10mg tablet configuration simplifies daily protocol management, and 50 tablets per bottle provides a complete supply for standard 6- to 8-week lean mass or bulking cycles.
Key Benefits
- Rapid Lean Muscle Growth: Drives significant increases in lean tissue mass without subcutaneous fluid retention.
- Targeted Tissue Selectivity: High affinity for skeletal muscle and bone receptors with minimal impact on prostate or secondary organs.
- Explosive Strength & Power: Accelerates recovery times and enhances raw lifting capacity within the first few weeks.
- Zero Aromatization: Resists conversion to estrogen entirelyβno risks of fluid bloat or estrogenic gynecomastia.
- Bone Density Support: Stimulates bone mineral density and connective tissue resilience under heavy training loads.
Administration & Usage Guidelines
- Half-Life & Timing: LGD-4033 has an extended active elimination half-life of approximately 24 to 36 hours. It is taken once daily with water, with or without food.
- Protocol Duration: Standard research cycles run 6 to 8 weeks to balance performance output with hormonal recovery.
- Swallowing: Swallow tablets whole with water. Do not crush or chew.
Important Safety Points
- Non-Aromatizing: Does not convert into estrogen or dihydrotestosterone (DHT).
- Endogenous Suppression: Suppresses natural testosterone levels at performance dosages; running a mini-PCT (e.g., Nolvadex or Clomid) post-cycle is recommended to restore HPTA function smoothly.
- Non-Hepatotoxic: As a non-steroidal SARM, it does not possess the C17-alpha alkylation structure of traditional oral steroids, placing minimal strain on liver tissue.
Safety Notice
WARNING: Selective Androgen Receptor Modulator (SARM). Causes dose-dependent suppression of endogenous testosterone output; run a structured Post-Cycle Therapy (SERM-based PCT) following cycle completion. Strictly contraindicated in pregnant or breastfeeding females, or individuals under 18 years of age.

Reviews
There are no reviews yet.